PureCycle Technologies, Inc. | ||||||||
(Exact Name of Registrant as Specified in its Charter) |
Delaware | 001-40234 |
86-2293091 | ||||||||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||||||||
5950 Hazeltine National Drive, | Suite 300, | Orlando | 32822 | ||||||||||||||
Florida | |||||||||||||||||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol(s) |
Name of each exchange on
which registered
|
||||||||||||
Common Stock, par value $0.001 per share | PCT | The Nasdaq Stock Market LLC | ||||||||||||
Warrants, each exercisable for one share of common stock, $0.001 par value per share, at an exercise price of $11.50 per share | PCTTW | The Nasdaq Stock Market LLC | ||||||||||||
Units, each consisting of one share of common stock, $0.001 par value per share, and three quarters of one warrant | PCTTU | The Nasdaq Stock Market LLC |
Exhibit Number | Description of Exhibit | ||||
99.1 | |||||
99.2 | |||||
99.3 | |||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Delivery Requirement: | Submission Compliance | ||||
Interim Financial Statements (Guarantor) | See Form 10-Q for the period ended 9/30/2023 as filed with the SEC. | ||||
Interim Financial Statements (Company) | Included herein | ||||
Compliance Certificates | Included herein for Guarantor and Company | ||||
Operating Statements
a) Budget to Actual for the period
b) Total product sold
c) Amount of Product sold under offtake contracts (in total) and amount of other products sold (with information about sale/purchaser)
d) Production Yield and values by weight/value
e) Supplied waste processed by weight / values
f) IHS/Chemical Data indices used
g) Terms/ extensions / replacements of Offtake or Feedstock contracts
h) Additional production capacity under development
i) hours of operation for the Project
|
a) Refer to budget to actual
b) Not applicable for Q3. There has been no product sold.
c) Not applicable for Q3. There has been no product sold under Offtake Contracts or of other Products which require disclosure.
d) Zero.
e) 2.4M lbs. processed for the quarter ended September 30, 2023.
f) IHS Average Price for Q3 = $0.5617/lb
Chemical Market Data Q3 = $0.3617/lb
g) None other than those previously disclosed.
h) Not applicable. There have been no changes to production capacity.
i) Zero hours of beneficial operations.
|
||||
Reconciliation Statements (Operating Revenue Fund) | Not applicable for Q3. |
Page | |||||
Unaudited Consolidated Financial Statements
|
|||||
Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 |
4 |
||||
Unaudited Statements of Operations for the Three Months Ended September 30, 2023 and 2022 |
|||||
Unaudited Statements of Member's Equity for the Nine months ended September 30, 2023 and 2022 |
6 | ||||
Unaudited Statements of Cash Flows for for the Nine months ended September 30, 2023 and 2022 |
|||||
Comparison of Actual to Budgeted Results for the Three Months Ended September 30, 2023 and 2022 |
|||||
Covenant Compliance for the Three Months Ended September 30, 2023 |
(Unaudited) | |||||||||||
(in thousands) | September 30, 2023 | December 31, 2022 | |||||||||
CURRENT ASSETS | |||||||||||
Cash and cash equivalents | $ 780 | $ 50,928 | |||||||||
Restricted cash - current | 19,827 | 29,389 | |||||||||
Prepaid expense and other current assets | 6,449 | 1,612 | |||||||||
Total current assets | 27,056 | 81,929 | |||||||||
Restricted cash - noncurrent | 150,149 | 93,415 | |||||||||
Property, plant and equipment, net | 420,959 | 373,848 | |||||||||
Operating lease right-of-use assets | 4,802 | 5,042 | |||||||||
Other long term assets | 4,071 | 4,206 | |||||||||
TOTAL ASSETS | $ 607,037 | $ 558,440 | |||||||||
LIABILITIES AND MEMBER'S EQUITY | |||||||||||
CURRENT LIABILITIES | |||||||||||
Accounts payable | $ 1,706 |
$ 816 |
|||||||||
Accrued expenses | 18,602 | 26,715 | |||||||||
Accrued interest | 6,127 | 1,532 | |||||||||
Current portion of long-term debt | 3,425 |
— |
|||||||||
Total current liabilities | 29,860 |
29,063 |
|||||||||
Deferred revenue | 5,000 | 5,000 | |||||||||
Bonds payable | 230,901 | 233,513 | |||||||||
Operating lease right-of-use liabilities | 3,633 | 3,956 | |||||||||
Other Liabilities | 1,054 | 1,117 | |||||||||
Due to parent | 282,766 | 188,989 | |||||||||
TOTAL LIABILITIES | $ 553,214 |
$ 461,638 |
|||||||||
MEMBER'S EQUITY | |||||||||||
LLC Member Interest | 223,387 | 223,387 | |||||||||
Accumulated deficit | (169,564) | (126,585) | |||||||||
TOTAL MEMBERS' EQUITY | $ 53,823 | $ 96,802 | |||||||||
TOTAL LIABILITIES AND MEMBERS' EQUITY | $ 607,037 |
$ 558,440 |
Three months ended September 30, | |||||||||||
2023 | 2022 | ||||||||||
(in thousands) | |||||||||||
Costs and expenses | |||||||||||
Operating costs | $ | 17,323 | $ | 3,076 | |||||||
Research and development | 48 | 210 | |||||||||
Selling, general and administrative | 2,692 | 1,942 | |||||||||
Total operating costs and expenses | 20,063 | 5,228 | |||||||||
Interest expense (income), net | 3,315 | (481) | |||||||||
Other expense | (13) | (32) | |||||||||
Total other expense |
3,302 | (513) | |||||||||
Net loss | $ | (23,365) | $ | (4,715) |
For the nine months ended September 30, 2023 | ||||||||||||||||||||
(in thousands) | LLC Member Interest | Accumulated deficit | Total Member's Equity | |||||||||||||||||
Balance, December 31, 2022 | $ 223,387 | $ (126,585) | $ 96,802 | |||||||||||||||||
Net Loss | — | (6,685) | (6,685) | |||||||||||||||||
Balance, March 31, 2023 | $ 223,387 | $ (133,270) | $ 90,117 | |||||||||||||||||
Net Loss | — | (12,929) | (12,929) | |||||||||||||||||
Balance, June 30, 2023 | $ 223,387 | $ (146,199) | $ 77,188 | |||||||||||||||||
Net Loss | — | $ (23,365) | (23,365) | |||||||||||||||||
Balance, September 30, 2023 | $ 223,387 | $ (169,564) | $ 53,823 | |||||||||||||||||
For the nine months ended September 30, 2022 | ||||||||||||||||||||
(in thousands) | LLC Member Interest | Accumulated deficit | Total Member's Equity | |||||||||||||||||
Balance, December 31, 2021 | $ 223,387 | $ (104,276) | $ 119,111 | |||||||||||||||||
Net Loss | — | (5,480) | (5,480) | |||||||||||||||||
Balance, March 31, 2022 | $ 223,387 | $ (109,756) | $ 113,631 | |||||||||||||||||
Net Loss | — | (5,459) | (5,459) | |||||||||||||||||
Balance, June 30, 2022 | $ 223,387 | $ (115,215) | $ 108,172 | |||||||||||||||||
Net Loss | — | (4,715) | (4,715) | |||||||||||||||||
Balance, September 30, 2022 | $ 223,387 | $ (119,930) | $ 103,457 |
Nine months ended September 30, | ||||||||||||||
2023 | 2022 | |||||||||||||
Cash flows from operating activities | ||||||||||||||
Net loss |
$ | (42,979) | $ | (15,654) | ||||||||||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||||||||||
Depreciation expense | 13,149 | 1,935 | ||||||||||||
Accretion of debt instrument discounts | 192 | 177 | ||||||||||||
Amortization of debt issuance costs | 621 | 569 | ||||||||||||
Operating lease amortization | 874 | 126 | ||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||
Prepaid expenses and other current assets | (4,837) | (1,723) | ||||||||||||
Prepaid expenses and other non-current assets | 135 | 24 | ||||||||||||
Accounts payable | 982 | 1,031 | ||||||||||||
Accrued expenses | 1,619 | 1,505 | ||||||||||||
Accrued interest | 6,019 | 324 | ||||||||||||
Operating right-of-use liabilities | (686) | (122) | ||||||||||||
Net cash used in operating activities | $ | (24,911) | $ | (11,808) | ||||||||||
Cash flows from investing activities | ||||||||||||||
Purchases of property, plant and equipment | (71,818) | (124,628) | ||||||||||||
Net cash used in investing activities | $ | (71,818) | $ | (124,628) | ||||||||||
Cash flows from financing activities | ||||||||||||||
Due to Parent | 93,777 | 39,216 | ||||||||||||
Payments on capital leases | (23) | (31) | ||||||||||||
Net cash provided by financing activities | $ | 93,754 | $ | 39,185 | ||||||||||
Net (decrease) increase in cash and restricted cash | (2,976) | (97,251) | ||||||||||||
Cash and restricted cash, beginning of year | 173,732 | 229,561 | ||||||||||||
Cash and restricted cash, end of year | $ | 170,756 | $ | 132,310 | ||||||||||
Supplemental disclosure of cash flow information | ||||||||||||||
Non-cash operating activities: | ||||||||||||||
Interest paid during the period, net of capitalized interest | $ | 650 | $ | 650 | ||||||||||
Non-cash investing activities: | ||||||||||||||
Additions to property, plant, and equipment in accrued expenses | $ | 14,968 | $ | 19,586 | ||||||||||
Additions to property, plant, and equipment in accounts payable |
$ | 422 | $ | 367 | ||||||||||
Additions to property, plant, and equipment in accrued interest | $ | — | $ | 4,271 |
For the Quarter Ended September 30, 2023 | |||||||||||||||||||||||||||||
Actual | Budget | $ Variance | % Variance | Explanations | |||||||||||||||||||||||||
(in thousands) | favorable / (unfavorable) | ||||||||||||||||||||||||||||
Costs and expenses | |||||||||||||||||||||||||||||
Operating costs | $ | 17,323 | $ | 16,617 | $ (706) | (4) % | ~$5.3M unfavorable non-cash depreciation expense, offset by favorable variances in variable costs due to production delays. | ||||||||||||||||||||||
Research and development | 48 | 40 | (8) | (20) % | immaterial for review | ||||||||||||||||||||||||
Selling, general and administrative | 2,692 | 5,456 | 2,764 | 51 % | ~$2M favorable for shared services allocation vs. budget for Q3 | ||||||||||||||||||||||||
Total operating costs and expenses | 20,063 | 22,113 | 2,050 | 9 % | |||||||||||||||||||||||||
Interest expense, net | $ 3,315 | $ 4,872 | $ 1,557 | 32 % | $4.8M of interest expense offset by $1.6M of interest income | ||||||||||||||||||||||||
Other expense | (13) | — | 13 | 100 % | immaterial for review | ||||||||||||||||||||||||
Total other expense, net | $ 3,302 | $ 4,872 | $ 1,570 | 32 % | |||||||||||||||||||||||||
Net loss | $ | (23,365) | $ | (26,985) | $ 3,620 | 13 % |
Days Cash on Hand: >75 | As of September 30, 2023 | |||||||
Cash on Hand1 | $ | 102,970 | ||||||
Operating Expenses2 | (11,275) | |||||||
Debt Service for Period3 | — | |||||||
Total Operating Expenses + Debt Service | $ | (11,275) | ||||||
Daily Cash Required4 | 123 | |||||||
Days Cash on Hand | 840 | pass |
Minimum Cash Required (at least $100M) | As of September 30, 2023 | |||||||
Cash & cash equivalents | $ | 780 | ||||||
Liquidity Escrow Reserve | 51,186 | |||||||
PureCycle Trustee Account | 51,003 | |||||||
Operating Revenue Escrow Fund | 273 | |||||||
Total Cash | $ | 103,242 | pass |